Q15648 (MED1_HUMAN) Homo sapiens (Human)
Mediator of RNA polymerase II transcription subunit 1 UniProtKBInterProSTRINGInteractive Modelling
1581 aa; Sequence (Fasta) ; (Isoform 3)
Available Structures
59 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| CryoEM structure of TR-TRAP |
Heteromer O43513; O60244; O75448; O75586; Q13503; Q15528; Q6P2C8; Q71SY5; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9UHV7; Q9ULK4; Q9Y2X0; Q9Y3C7; | 100.0 | ||||
| Human Mediator (deletion of MED1-IDR) in a Tail-extended conformation |
Heteromer A0JLT2; O43513; O60244; O75448; O75586; O95402; Q13503; Q15528; Q6P2C8; Q71SY5; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7; | 100.0 | 2×ZN; | |||
| Human Mediator (deletion of MED1-IDR) in a Tail-bent conformation (MED-B) |
Heteromer A0JLT2; O43513; O60244; O75448; O75586; O95402; Q13503; Q15528; Q6P2C8; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7; | 100.0 | 1×ZN; | |||
| Structure of human transcriptional Mediator complex |
Heteromer A0JLT2; O43513; O60244; O75448; O75586; P24863; P49336; Q13503; Q15528; Q6P2C8; Q93074; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9UHV7; Q9ULK4; Q9Y2X0; Q9Y3C7; | 100.0 | 4×ZN; | |||
| The IDRc bound human core Mediator complex |
Heteromer A0JLT2; O43513; O60244; O75448; O75586; Q13503; Q15528; Q6P2C8; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9UHV7; Q9ULK4; Q9Y2X0; Q9Y3C7; | 100.0 | 2×ZN; | |||
| Crystal structure of PPAR gamma in complex with Mediator of RNA polymerase II transcription subunit… |
Heteromer P37231; | 100 | 1×EDK; | |||
| Crystal structure of PPARgamma ligand binding domain in complex with TRAP220 peptide and agonist ro… |
Heteromer P37231; | 100 | 1×BRL; | |||
| Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and … |
Heteromer P13053; | 100 | 1×VD4; | |||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer P13053; | 100 | 1×O11; | |||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer P13053; | 100 | 1×W07; | |||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer P13053; | 100 | 1×W12; | |||
| Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands |
Heteromer P13053; | 100 | 1×T08; | |||
| Crystal structure of VDR-LBD complexed with 2-methylidene-19-nor-1a,25-dihydroxyvitamin D3 |
Heteromer P13053; | 100 | 1×YSV; | |||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a s… |
Heteromer P13053; | 100 | 1×VD1; | |||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer P13053; | 100 | 1×4OA; | |||
| A mixed population of antagonist and agonist binding conformers in a single crystal explains partia… |
Heteromer P13053; | 100 | 1×YA1; | |||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer P13053; | 100 | 1×3KL; | |||
| Crystal structure of VDR-LBD complexed with 25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-… |
Heteromer P13053; | 100 | 1×8BO; 1×9RO; | |||
| Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and … |
Heteromer P13053; | 100 | 1×VD5; | |||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synt… |
Heteromer P13053; | 100 | 1×VDZ; | |||
| Crystal structure of VDR-LBD complexed with 2-methylidene-26,27-diphenyl-19-nor-1,25-dihydroxyvitam… |
Heteromer P13053; | 100 | 1×AKX; | |||
| Vitamin D receptor with a synthetic ligand ADRO2 |
Heteromer P13053; | 100 | 1×8J3; | |||
| A mixed population of antagonist and agonist binding conformers in a single crystal explains partia… |
Heteromer P13053; | 100 | 1×YA1; | |||
| Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a e… |
Heteromer P13053; | 100 | 1×9KR; | |||
| Crystal structure of VDR-LBD complexed with 22S-butyl-2-methylidene-19-nor-1a,25-dihydroxyvitamin D3 |
Heteromer P13053; | 100 | 1×YS9; | |||
| Crystal structure of VDR-LBD complexed with 22S-Butyl-25RS-(hydroxyphenyl)-25-methoxy-2-methylidene… |
Heteromer P13053; | 100 | 1×8C0; | |||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer P13053; | 100 | 1×LOA; | |||
| Crystal structure of VDR-LBD/partial agonist complex: 22S-hexyl analogue |
Heteromer P13053; | 100 | 1×YSL; | |||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxy… |
Heteromer P13053; | 100 | 1×VDX; | |||
| crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a s… |
Heteromer P13053; | 100 | 1×VD2; | |||
| Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid de… |
Heteromer P13053; | 100 | 1×LHP; | |||
| Covalent labeling of rVDR-LBD by turn-on fluorescent probe mediated by conjugate addition and cycli… |
Heteromer P13053; | 100 | 1×YSV; 1×EJO; | |||
| Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having an … |
Heteromer P13053; | 100 | 1×9KX; 1×9N9; | |||
| Crystal structure of VDR-LBD complexed with 22R-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1 ,2… |
Heteromer P13053; | 100 | 1×YA2; | |||
| Interaction between Vitamin D receptor (VDR) and a ligand having a dienone group |
Heteromer P13053; | 100 | 1×9KX; | |||
| Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a v… |
Heteromer P13053; | 100 | 1×9K0; | |||
| Crystal structure of VDR-LBD/partial agonist complex: 22S-ethyl analogue |
Heteromer P13053; | 100 | 1×YSE; | |||
| Development of Novel Lithocholic Acid Derivatives as Vitamin D Receptor Agonists |
Heteromer P13053; | 100 | 1×D0O; | |||
| VDR ligand binding domain in complex with 2-Methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydr… |
Heteromer P13053; | 100 | 1×YSD; | |||
| Vitamin D3 receptor/lithochoric acid derivative complex |
Heteromer P13053; | 100 | 1×FKF; 1×FMT; | |||
| Vitamin D receptor complex with a carborane compound |
Heteromer P13053; | 100 | 1×10S; | |||
| Vitamin D receptor complexed with a lithocholic acid derivative |
Heteromer P13053; | 100 | 1×7SW; | |||
| Vitamin D receptor complex with a carborane compound |
Heteromer P13053; | 100 | 1×10R; | |||
| VDR ligand binding domain in complex with 2-Methylidene-19,24-dinor-1alpha,25-dihydroxy vitaminD3 |
Heteromer P13053; | 100 | 1×YS3; | |||
| Vitamin D3 receptor/lithochoric acid derivative complex |
Heteromer P13053; | 100 | 1×FKC; 1×FMT; | |||
| Vitamin D receptor with a synthetic ligand ADRO1 |
Heteromer P13053; | 100 | 1×8J0; 1×FMT; | |||
| Crystal structure of VDR-LBD complexed with 25-(hydroxyphenyl)-2-methylidene-19,26,27-trinor-25-oxo… |
Heteromer P13053; | 100 | 1×8BL; | |||
| Crystal structure of vitamin D receptor ligand binding domain complexed with a 19-norvitamin D comp… |
Heteromer P13053; | 100 | 1×YW2; | |||
| Crystal structure of VDR in complex with DLAM-2P |
Heteromer P13053; | 100 | 1×DLC; | |||
| Crystal structure of VDR in complex with DLAM-4P (P21 form) |
Heteromer P13053; | 100 | 1×VDP; | |||
| VDR complex - calcitroic acid |
Heteromer Q9PTN2; | 100 | 1×2QI; | |||
| VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha… |
Heteromer P13053; | 100 | 1×YS5; | |||
| VDR ligand binding domain in complex with 2-Mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvita… |
Heteromer P13053; | 100 | 1×YS2; | |||
| Crystal structure of VDR-LBD complexed with an antagonist, 2-methylidene-19,26,27-trinor-22-(S)-but… |
Heteromer P13053; | 100 | 1×8FF; | |||
| Crystal structure of VDR-LBD complexed with 25RS-(Hydroxyphenyl)-2-methylidene-19,26,27-trinor-1,25… |
Heteromer P13053; | 100 | 1×8BF; | |||
| Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR335 and a sy… |
Heteromer P13053; | 100 | 1×YR4; | |||
| Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a sy… |
Heteromer P13053; | 100 | 1×YR3; | |||
| Crystal structure of VDR in complex with DLAM-4 (C2 form) |
Heteromer P13053; | 100 | 1×VDP; | |||
| Crystal structure of the rat vitamin D receptor ligand binding domain complexed with TEI-9647 and a… |
Heteromer P13053; | 100 | 1×TEJ; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8tqw.1.F | monomer | 0.62 | 100.00 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 3 | 7emf.1.A | monomer | 0.70 | 99.82 | |||